Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

NCT06017622 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2026-02-17

No results posted yet for this study

Summary

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of pediatric patients who visit the emergency department due to acute cannabis-induced CNS depression.

Conditions

  • Acute Cannabis-induced CNS Depression

Sponsors & Collaborators

  • Anebulo Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Ken Cundy, PhD · Anebulo Pharmaceuticals Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2026-12-30
Completion
2026-12-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06017622 on ClinicalTrials.gov